August 9, 2021
A growing list of the available psychedelics stocks to watch out for from the Investing News Network.
May 26, 2020
The drug development process can be incredibly costly, both in terms of the financial commitment required and the time necessary...
May 15, 2020
Algernon Pharmaceuticals, a clinical stage pharmaceutical development company, is pleased to announce that it has submitted for ethics approval in...
May 6, 2020
Algernon Pharmaceuticals has received ethics approval for the planned Phase 2 clinical study of its re-purposed drug NP-120 (Ifenprodil).
May 5, 2020
Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: AGNPF) has amended certain terms of its brokered private placement, being conducted...
May 1, 2020
Algernon Pharmaceuticals a clinical stage pharmaceutical development company, has entered into an agreement with Mackie Research Capital Corporation
April 30, 2020
Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) has received a No Objection Letter from Health Canada to proceed...